Thalidomide as treatment of crohn-like disease occurred after allogeneic hematopoietic stem cell transplantation in a pediatric patient.
Stefano GiardinoCecilia BavaSerena ArrigoFilomena PierriPaolo GandulliaCristina CocciaMaura FaraciPublished in: Pediatric transplantation (2020)
Thalidomide could represent a therapeutic option to treat CD as autoimmune disease after allogeneic HSCT.